Vicarious Surgical Inc. (OTC: RBOT)

Vicarious Surgical is developing advanced robotic systems for minimally invasive surgery, focusing on a single-port surgical platform that combines miniaturized robotics, computer science, sensing, and 3D visualization. The company aims to transport surgeons inside the patient to perform procedures with greater dexterity, visibility, and sensor-based feedback through a small abdominal incision. Its core technology is designed to overcome limitations of existing open surgery, laparoscopic, and robot-assisted surgical systems by enabling human-equivalent motion and expanded access within the abdomen.

Vicarious Surgical generates revenue primarily through the anticipated sale of its Vicarious Surgical System and associated disposable instruments and accessories once the device receives FDA authorization and is commercialized. The company plans to offer the robotic system along with maintenance and service support, with a recurring revenue model driven by the sale of single-use components such as robotic arms, camera tips, and instrument tips. Revenue will depend on system adoption by hospitals and ambulatory surgical centers seeking to improve surgical workflow, reduce costs, and increase procedural efficiency.

The company operates through the following segments:

• Vicarious Surgical System. This segment encompasses the development and planned commercialization of the single-port surgical robotic platform, including the camera and instrument arms, surgeon console, and patient cart. The system is designed to provide nine degrees of freedom per instrument arm, human-equivalent motion, enhanced visualization via a stereoscopic camera, and real-time force and motion sensing through 28 sensors per instrument arm. It is intended to support a broad range of soft tissue abdominal and gynecological procedures, with initial focus on ventral hernia repair.

Vicarious Surgical positions itself as an innovator in the surgical robotics industry, aiming to address key barriers to adoption of robotic-assisted surgery such as high capital costs, large system footprint, limited dexterity, difficult usability, and low utilization rates. The company differentiates itself through its proprietary de-coupled actuator architecture, which reduces mechanical interdependence between joints to improve mobility, strength, and form factor. Its small single-port design allows mobility across operating rooms without requiring dedicated space, potentially lowering costs and improving accessibility for hospitals and ambulatory surgical centers. Key competitors include Intuitive Surgical, Johnson & Johnson (via Ethicon Endo-Surgery and Verb Surgical), Medtronic (via Covidien), Virtual Incision, Stryker, and CMR Surgical.

The company intends to serve hospitals and ambulatory surgical centers that perform soft tissue abdominal and gynecological procedures, including ventral hernia repair, hysterectomy, cholecystectomy, and other gastrointestinal surgeries. Vicarious Surgical targets surgeons and medical facilities seeking to adopt minimally invasive techniques with improved ergonomics, procedural efficiency, and patient outcomes, particularly in outpatient settings where cost, flexibility, and training accessibility are critical factors.